Finding:

1. close

   Ecromeximab

   Ecromeximab is a chimeric monoclonal antibody is used in the treatment of malignant melanoma. This drug was developed by Kyowa Hakko Kogyo Co., Ltd.
2. close

   Monoclonal antibodies

   Ecromeximab
3. close

   Bavituximab

   Ecromeximab
4. close

   Cetuximab

   Ecromeximab
5. close

   Volociximab

   Ecromeximab
6. close

   Teneliximab

   Ecromeximab
7. close

   Pagibaximab

   Ecromeximab
8. close

   Galiximab

   Ecromeximab
9. close

   Basiliximab

   Ecromeximab
10. close

    Vapaliximab

    Ecromeximab

Explore the following pages on Powerset:

• Ecromeximab,
• Monoclonal antibodies,
• Bavituximab,
• Cetuximab,
• Volociximab,
• Teneliximab,
• Pagibaximab,
• Galiximab,
• Basiliximab,
• Vapaliximab